Item 8.01. Other Events.
On May 14, 2008, Edward K. Aldag, Jr., Chairman of the Board, President and
Chief Executive Officer of Medical Properties Trust, Inc. (the "Company"),
entered into a written stock selling plan (the "10b5-1 Plan") in accordance with
Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, and the
Company's Insider Trading Policy.
Under Rule 10b5-1, directors, officers and other employees may adopt a
pre-arranged plan or contract for the sale of Company securities under specified
conditions and at specified times when they are not in possession of material
non-public information. Using 10b5-1 plans, individuals can gradually diversify
their investment portfolios, or raise funds for income tax obligations or other
needs, by spreading stock trades out over an extended period of time so as to
reduce market impact and avoid concerns about transactions occurring at a time
when they might possess material non-public information.
The 10b5-1 Plan entered into by Mr. Aldag allows for the sale of a maximum of
approximately 186,000 shares of the Company's common stock, par value $0.001 per
share, over a six-month period beginning on May 22, 2008. Sales of shares by
Mr. Aldag pursuant to the 10b5-1 Plan provide for sales of specified share
amounts on the open market on specified dates at prevailing market prices. Such
sales are being made by Mr. Aldag for income tax purposes and other financial
planning needs.
Transactions made under the 10b5-1 Plan will be disclosed publicly through
Form 144 and Form 4 filings with the Securities and Exchange Commission. Except
as may be required by law, the Company does not undertake to report on specific
Rule 10b5-1 pre-planned stock trading plans of Company officers, nor to report
modifications or terminations of the aforementioned 10b5-1 Plan or the plan of
any other individual.